Thanks FF. Is that how it normally works? i.e. the waiver is supplementary to the FDA approval and is granted after the fact? I thought it was part of the submission itself.
I feel like this is super, super important - if the CLIA waiver is granted, it's validation that the 'ease of use' is actually a competitive advantage. Until then, we're just another covid test on the market right?
AT1 Price at posting:
19.0¢ Sentiment: Buy Disclosure: Held
